Names |
- Fasciitis with eosinophilia syndrome
- Pansclerotic morphea with deep fascial involvement
Category: Systemic |
Prevalence |
From 3,333 to 6,999 cases in the US (Spielmann 2018). Female/Male ratio: 2.3x. |
Age of Onset |
Onset typically occurs between ages 30 and 60. |
Description |
Eosinophilic fasciitis is a rare, scleroderma-like, autoimmune rheumatic disorder in which the skin and tissue (the fascia, fibrous tissue that separates different layers of tissues under the skin) that lies beneath the skin become painfully inflamed and swollen and gradually hardens. It affects the forearms, the upper arms, the lower legs, the thighs, and the trunk (in order of decreasing frequency). The disease is considered by some to be a deep variant of the skin condition morphea, and is also known as pansclerotic morphea with deep fascial involvement. Patients usually present suddenly with painful, tender, swollen and red extremities. Within weeks to months, patients develop stiffness and affected skin becomes hardened, creating a characteristic orange-peel appearance over the surfaces of the extremities. In severely affected areas, the skin and the subcutaneous tissue are bound tightly to the underlying muscle. This creates a woody-type appearance. The presentation of eosinophilic fasciitis is similar to scleroderma or systemic sclerosis. However unlike scleroderma it affects the fascia, not the skin (dermis). Unlike scleroderma and systemic sclerosis, effects such as Raynaud's phenomenon, which affects prominent small blood vessels in the extremities (telangiectasia), and visceral changes, such as swallowing problems, are absent. It was first characterized in 1974 and it is not yet known whether it is actually a distinct condition or just a different presentation of morphea.
Not confirmed as an autoimmune or autoinflammatory disease. ICD-10 Code: M35.4     SNOMED Code: 24129002
|
Patient Groups |
|
Bloggers |
|
Symptoms |
|
Resources |
Link to Clinical Trials Link to PubMed |
References |
Link to Mayo Clinic Link to Cleveland Clinic Link to Healthline
|
|
Profile by: Autoimmune RegistryProfile updated September 2024Charts generated Oct 12, 2024 at 12:54 PM ET |
|
Fasciitis with eosinophilia syndrome sex breakdown
Please wait while the Fasciitis with eosinophilia syndrome sex breakdown results are loaded
Fasciitis with eosinophilia syndrome age breakdown
Please wait while the Fasciitis with eosinophilia syndrome age breakdown results are loaded
|
Graphs for this disease are generated based on data from the Autoimmune Registry Inc.
Fasciitis with eosinophilia syndrome top comorbidities/symptoms
Chart is omitted due to low report count.
Please wait while the Fasciitis with eosinophilia syndrome top comorbidities/symptoms results are loaded
Fasciitis with eosinophilia syndrome top autoimmune comorbidities
Please wait while the Fasciitis with eosinophilia syndrome top autoimmune comorbidities results are loaded
* Disease is suspected as autoimmune, but unconfirmed. Data Source: Graphs on this page represent data from the Autoimmune Registry Inc.
here. To protect participant anonymity, results derived from fewer than 5 participants are not graphed. The Autoimmune Registry Inc is a 501(c)(3) non-profit supported by donors like you.
Anti-inflammatory / specialty medications and supplements
Please wait while the Anti-inflammatory / specialty medications and supplements results are loaded
Fasciitis with eosinophilia syndrome top immunosuppressants / autoimmune therapies
Please wait while the Fasciitis with eosinophilia syndrome top immunosuppressants / autoimmune therapies results are loaded
* Biologic medications. Data Source: Graphs on this page represent data in electronic health records from the All of Us research database. As of July 2024, there are 451,000 sets of electronic health records collected from participants. A snapshot of the data can be found
here. To protect participant anonymity, results derived from fewer than 20 participants are not graphed.
The All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the All of Us Research Program would not be possible without the partnership of its participants.
Patient-reported 7-day average pain
Chart is omitted due to low report count.
Please wait while the Patient-reported 7-day average pain results are loaded
Patient-reported 7-day average fatigue
Chart is omitted due to low report count.
Please wait while the Patient-reported 7-day average fatigue results are loaded
General physical health
Chart is omitted due to low report count.
Please wait while the General physical health results are loaded
General mental health
Chart is omitted due to low report count.
Please wait while the General mental health results are loaded
Social and relationship satisfaction
Chart is omitted due to low report count.
Please wait while the Social and relationship satisfaction results are loaded
General quality of life
Chart is omitted due to low report count.
Please wait while the General quality of life results are loaded
Ability to carry out social roles and activities
Chart is omitted due to low report count.
Please wait while the Ability to carry out social roles and activities results are loaded
Data Source: Graphs on this page represent data in self-reported survey results from the All of Us research database. As of July 2024, there are 560,000 participants who have completed these surveys. This dataset, however, may not be representative of the US population. A snapshot of the data can be found
here. To protect participant anonymity, results derived from fewer than 20 participants are not graphed.
The All of Us Research Program is supported by the National Institutes of Health, Office of the Director: Regional Medical Centers: 1 OT2 OD026549; 1 OT2 OD026554; 1 OT2 OD026557; 1 OT2 OD026556; 1 OT2 OD026550; 1 OT2 OD 026552; 1 OT2 OD026553; 1 OT2 OD026548; 1 OT2 OD026551; 1 OT2 OD026555; IAA #: AOD 16037; Federally Qualified Health Centers: HHSN 263201600085U; Data and Research Center: 5 U2C OD023196; Biobank: 1 U24 OD023121; The Participant Center: U24 OD023176; Participant Technology Systems Center: 1 U24 OD023163; Communications and Engagement: 3 OT2 OD023205; 3 OT2 OD023206; and Community Partners: 1 OT2 OD025277; 3 OT2 OD025315; 1 OT2 OD025337; 1 OT2 OD025276. In addition, the All of Us Research Program would not be possible without the partnership of its participants.
Concerns about ability to pay
Chart is omitted due to low report count.
Please wait while the Concerns about ability to pay results are loaded
Feeling unheard by healthcare providers
Chart is omitted due to low report count.
Please wait while the Feeling unheard by healthcare providers results are loaded
Patient employment status
Chart is omitted due to low report count.
Please wait while the Patient employment status results are loaded
Patient insurance coverage
Chart is omitted due to low report count.
Please wait while the Patient insurance coverage results are loaded
Graphs for this disease are generated based on data from the Autoimmune Registry Inc.